Distribute the next generation of microbiome wellness.

Medalta partners with regional distributors, pharmacy chains and clinical channels to bring scientifically-grounded, microbiome-derived products to new markets — with the regulatory, marketing and supply support to do it properly.

Partner with us
Why Medalta

A portfolio built on real science.

We make microbiome-derived products from characterised strains, clinically-studied actives and a formulation discipline borrowed from pharmaceuticals — not from supplements. That's the story you get to tell on shelf.

01

Clinically-grounded formulations

Every product is built around characterised strains and dose-justified actives. We share clinical references, mechanism notes and dosing rationale so your teams can sell from facts, not folklore.

02

GMP & ISO manufacturing

Manufactured in EU facilities to GMP and ISO 22000 standards, with HACCP-controlled supply chains and full batch documentation — ready for the most demanding regulatory regimes.

03

Regulatory dossiers, market-ready

Notification-ready dossiers, ingredient declarations and translated labelling for the EU, EFTA, GCC and selected APAC markets. We've already done the paperwork that slows most launches.

04

A brand built for the next decade

Three coherent product lines, one biological logic. Modern identity, premium pack design, and a consumer story that lifts the category instead of competing on price.

05

Partner-first commercial terms

Territory protection for exclusive partners, transparent volume tiers, predictable lead times and stock-up windows so your sell-in cadence doesn't surprise you.

Laboratory microscope
About

We are more than a science - we are a way of life

Each line addresses a different need
— but every formula traces back to the same library of characterised strains.

History

History

Our flagship anti-inflammatory programme. Postbiotic-derived, omega-stabilised, mechanism-led.

Medalta Lab

Medalta Lab

Our flagship anti-inflammatory programme. Postbiotic-derived, omega-stabilised, mechanism-led.

Bacteria-First

Bacteria-First

Our flagship anti-inflammatory programme. Postbiotic-derived, omega-stabilised, mechanism-led.

Numbers

The partner case, in figures.

A cross-section of where our work stands today. Living data — updated as new trials, strains and markets come online.

120+

Characterised bacterial strains in our reference library

9

Clinical or pre-clinical studies in active programmes

3.2M

Daily doses produced under GMP per year

14

International markets where Medalta is distributed

What you get

Everything you need to launch.

Partner with us

Regulatory dossier

Notification-ready files for EU, EFTA, GCC and selected APAC markets, plus ingredient and allergen declarations in your language.

Localised marketing kit

Translated packaging, claims you can actually use, photography, and video so retail buyers see one Medalta everywhere.

Training & certification

Live and on-demand training for your sales reps, pharmacists and clinical contacts, with a written certification at the end.

Predictable supply

EU-based manufacturing with ~6-week lead times, cold-chain options where strains demand it, and quarterly stock-up windows.

Co-marketing budget

Defined co-op budgets for in-store activation, digital, KOLs and trade events — released against an agreed quarterly plan.

A real human partner

One named account manager, one Slack channel, one regional medical lead — not a ticket queue and a PDF.

Certifications & compliance

Ready for any regulator.

GMP Certified

GMP Certified

Manufactured to international quality and safety standards

ISO Certified

ISO Certified

Compliant with globally recognized quality management standards

HACCP Certified

HACCP Certified

Ensures food safety through hazard control standards

Halal & Vegan

Halal & Vegan

Selected SKUs certified Halal and registered with The Vegan Society.

Markets

Where we are,
and where we're going.

Medalta is currently distributed in 14 markets across Europe, the GCC and South-East Asia. Twenty-two more are open for partner discussions in 2026.

Austria
Bulgaria
Czechia
Germany
Hungary
Italy
Poland
Romania
Slovakia
Slovenia
Spain
UAE
Saudi Arabia
Singapore
France Soon...
Greece Soon...
Ireland Soon...
Netherlands Soon...
Portugal Soon...
Sweden Soon...

Don't see your market?

If your country isn't listed, write to us anyway. We open new territories every quarter and we'd rather hear from you than miss the conversation.

Reach out
Start the conversation

Become a Medalta partner.

Tell us a little about your market and channels. We read every enquiry and aim to reply within two working days. If we're not the right fit today, we'll say so.

By submitting, you agree we may contact you about a possible partnership. We never
share your details with third parties.